Kanoria Chem. (KANORICHEM)

FairStock Score: 30/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹82.99, the market values Kanoria Chem at only 57% of its book value. As Graham taught, buying assets at a discount is attractive only if management can create value with them. Here, the scorecard is concerning: ROE at -2.14% and ROCE at -2.33% tell me the business is destroying value, not compounding it. The latest quarter shows a small profit of ₹4 Cr on sales of ₹266 Cr – a net margin of roughly 1.5% – which is a far cry from a healthy franchise. Sales growth of 47.39% is interesting, but growth without profits is just ego. A debt-to-equity ratio of 0.62 is manageable, but with negative returns, debt becomes a burden rather than a leverage tool. The Piotroski F-score of 6/9 is mediocre, neither signalling bankruptcy nor strength. Promoter holding of 74.4% aligns interests, though minority shareholders have little say. The 52-week range of ₹56 to ₹164.60 shows the stock halved from its high; the market is skeptical. Is this a value trap? Possibly. But at 0.57 times book, the downside is cushioned if assets are real. I need to see why returns are so poor. The company is trading near its low, but cheap can get cheaper. I would not buy simply because it is cheap; I need evidence that operational improvements are sustainable. Book value per share of ₹146.60 offers a margin of safety, but only if earnings power emerges. I will watch whether this recent profit can scale.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer